As Pfizer Inc. (NYSE: PFE) stock gained over 5% this week fueled by its strong second quarter 2026 earnings report, Finbold has observed its increased insider trading .
Two Pfizer directors, Ronald E. Blaylock and Mortimer J. Buckley spent a total of $1,959,190 to purchase PFE shares on August 5, according to data from Secform4, which Finbold analyzed on August 7. Specifically, Blaylock spent $998,821 to buy 39,231 Pfizer shares at an average price of $25.46, hence increasing shares stake to 71,688.
Receive Signals on SEC-verified Insider Stock Trades
This signal is triggered upon the reporting of the trade to the Securities and Exchange Commission (SEC).
Buckley bought 37,632 PFE shares for $960,369 at an average price of $25.52, thereby inflating the holdings to 37,632 shares. On the other hand, Danica Jennifer, the company’s Senior Vice President (SVP) and Controller, sold 3,278 Pfizer shares for $83,261 at an average price of $25.4, thus currently holding 28,611 shares.
As a result, Pfizer insider trading has resulted in a net purchase of about $1,875,929.
Why are top executives net-buying Pfizer stock?
Top executives at Pfizer are net buying PFE shares after the company delivered a strong quarterly earnings report, raised its full-year guidance, and announced billions in new cost cuts. Pfizer announced $15.03 billion in revenue, which beat analysts’ expectations of $14.41 billion.
Receive Signals on US Congress Members' Stock Trades
Stay up-to-date on the trading activity of US Congress members. The signal triggers based on updates from the House disclosure reports, notifying you of their latest stock transactions.
Additionally, the company raised its full-year 2026 guidance to a range of $60.5 billion to $62.5 billion, up from $59.5 billion to $62.5 billion. The upward adjustment was fueled by its newly acquired drugs that consist of non-COVID portfolio.
As such, several Wall Street analysts, including Vamil Divan at Guggenheim, have reiterated a Buy rating for Pfizer stock in the next 12 months. As of press time, 20 analysts surveyed by TipRanks have set an average 12-month target for PFE shares at $27.94, signaling a potential 5.96% upside.
Receive Signals on US Senators' Stock Trades
Stay up-to-date on the trading activity of US Senators. The signal triggers based on updates from the Senate disclosure reports, notifying you of their latest stock transactions.
PFE stock price outlook
Over the last 30 days, PFE stock price has surged by 8.94%, trading at $26.20 on Friday. Consequently, the company had a market capitalization of approximately $149.3 billion.
The company’s stock price is well positioned to rally further as insider net purchases boosts analysts and investors’ confidence.
